Cesana C - Search Results

1

Smouldering Waldenstrom's macroglobulinemia: factors predicting evolution to symptomatic disease.

Cesana C, Miqueleiz S, Bernuzzi P, Tresoldi E, Rossi V, D'avanzo G, Filippini D, Morra E. Cesana C, et al. Semin Oncol. 2003 Apr;30(2):231-5. doi: 10.1053/sonc.2003.50056. Semin Oncol. 2003. PMID: 12720142

2

Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.

Morra E, Cesana C, Klersy C, Barbarano L, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Miqueleiz S, Bernuzzi P, Nosari AM, Lazzarino M. Morra E, et al. Among authors: cesana c. Leukemia. 2004 Sep;18(9):1512-7. doi: 10.1038/sj.leu.2403442. Leukemia. 2004. PMID: 15322559

3

Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.

Morra E, Cesana C, Klersy C, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Barbarano L, Lazzarino M; Hematology/Oncology Studies and Trials (HOST) Group, Italy. Morra E, et al. Among authors: cesana c. Semin Oncol. 2003 Apr;30(2):172-7. doi: 10.1053/sonc.2003.50068. Semin Oncol. 2003. PMID: 12720131

4

Clinical characteristics and outcome of immunoglobulin M-related disorders.

Cesana C, Barbarano L, Miqueleiz S, Lucchesini C, Ricci F, Varettoni M, Filippini D, Lazzarino M, Morra E. Cesana C, et al. Clin Lymphoma. 2005 Mar;5(4):261-4. doi: 10.3816/clm.2005.n.012. Clin Lymphoma. 2005. PMID: 15794861

5

Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.

Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E. Cesana C, et al. J Clin Oncol. 2002 Mar 15;20(6):1625-34. doi: 10.1200/JCO.2002.20.6.1625. J Clin Oncol. 2002. PMID: 11896113

6

Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules.

Cesana C, Nosari AM, Klersy C, Miqueleiz S, Rossi V, Ferrando P, Valentini M, Barbarano L, Morra E. Cesana C, et al. Haematologica. 2003 Sep;88(9):1022-8. Haematologica. 2003. PMID: 12969810

7

Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies.

Morra E, Cesana C, Klersy C, Barbarano L, Miqueleiz S, Varettoni M, Lucchesini C, Ricci F, Lazzarino M. Morra E, et al. Among authors: cesana c. Clin Lymphoma. 2005 Mar;5(4):265-9. doi: 10.3816/clm.2005.n.013. Clin Lymphoma. 2005. PMID: 15794862

8

Successful treatment with voriconazole of cerebral aspergillosis in an hematologic patient.

Marbello L, Nosari A, Carrafiello G, Anghilieri M, Cesana C, Cafro AM, D'Avanzo G, Morra E. Marbello L, et al. Among authors: cesana c. Haematologica. 2003 Mar;88(3):ECR05. Haematologica. 2003. PMID: 12651283 Free article. No abstract available.

9

Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes.

Molteni A, Riva M, Cesana C, Speziale V, Nichelatti M, Scarpati B, Greco R, Ravano E, Cairoli R, Rossini S, Morra E. Molteni A, et al. Among authors: cesana c. Eur J Haematol. 2015 Jun;94(6):519-25. doi: 10.1111/ejh.12465. Epub 2014 Dec 4. Eur J Haematol. 2015. PMID: 25307971

10

Prognostic value of circulating CD34+ cells in myelodysplastic syndromes.

Cesana C, Klersy C, Brando B, Nosari A, Scarpati B, Scampini L, Molteni A, Nador G, Santoleri L, Formenti M, Valentini M, Mazzone A, Morra E, Cairoli R. Cesana C, et al. Leuk Res. 2008 Nov;32(11):1715-23. doi: 10.1016/j.leukres.2008.03.028. Epub 2008 May 5. Leuk Res. 2008. PMID: 18456323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters